Andrew Navia

Former Postdoctoral Fellow

Degrees & Affiliations

BS, Chemistry - Emory University PhD Candidate, Chemistry - MIT

Background & Interests

Biography

Andrew is a Chemistry PhD candidate in the Shalek Lab. He is interested developing novel RNA-seq technologies and studying resistance mechanisms in cancer. He captains the lab volleyball team, Seq-and-Destroy, and plays ice hockey in his free time.

As a chemistry major at Emory University, Andrew worked in Professor Dennis Liotta’s lab synthesizing nucleotide reverse transcriptase inhibitors.

Publications

Artificial variables help to avoid over-clustering in single-cell RNA sequencing

DenAdel et al.,
AJHG,
2025

Variants and vaccines impact nasal immunity over three waves of SARS-CoV-2

Walsh et al.,
Nature Immunology,
2025

AAV5 Delivery of CRISPR/Cas9 Mediates Genome Editing in the Lungs of Young Rhesus Monkeys

Liang et al.,
Human Gene Therapy,
2024

Mutation and cell state compatibility is required and targetable in Ph+ acute lymphoblastic leukemia minimal residual disease

Winter et al.,
biorxiv,
2024

Impact of variants and vaccination on nasal immunity across three waves of SARS-CoV-2

Long et al.,
biorxiv,
2024

An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfection

Ziegler et al.,
American Society for Microbiology,
2024

A knockoff calibration method to avoid over-clustering in single-cell RNA-sequencing

DenAdel et al.,
bioRxiv,
2024

Scalable nonparametric clustering with unified marker gene selection for single-cell RNA-seq data

Nwizu et al.,
bioRxiv,
2024

Scalable nonparametric clustering with unified marker gene selection for single-cell RNA-seq data

Nwizu et al.,
bioRxiv,
2024

Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity

Williams et al.,
Cancer Research,
2023